NBIX logo

Neurocrine Biosciences (NBIX) Total debt

Annual Total Debt:

$455.10M+$26.70M(+6.23%)
December 31, 2024

Summary

  • As of today (May 29, 2025), NBIX annual total debt is $455.10 million, with the most recent change of +$26.70 million (+6.23%) on December 31, 2024.
  • During the last 3 years, NBIX annual total debt has risen by +$14.70 million (+3.34%).
  • NBIX annual total debt is now -8.15% below its all-time high of $495.50 million, reached on December 31, 2019.

Performance

NBIX Total debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNBIXbalance sheet metrics

Quarterly Total Debt:

$447.50M-$7.60M(-1.67%)
March 31, 2025

Summary

  • As of today (May 29, 2025), NBIX quarterly total debt is $447.50 million, with the most recent change of -$7.60 million (-1.67%) on March 31, 2025.
  • Over the past year, NBIX quarterly total debt has dropped by -$64.40 million (-12.58%).
  • NBIX quarterly total debt is now -12.58% below its all-time high of $511.90 million, reached on March 31, 2024.

Performance

NBIX Quarterly Total Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNBIXbalance sheet metrics

Total debt Formula

Total Debt = Short Term Debt + Long Term Debt

NBIX Total debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+6.2%-12.6%
3 y3 years+3.3%-6.8%
5 y5 years-8.2%-10.4%

NBIX Total debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+73.1%-12.6%+78.0%
5 y5-year-8.2%+73.1%-12.6%+78.0%
alltimeall time-8.2%>+9999.0%-12.6%>+9999.0%

NBIX Total debt History

DateAnnualQuarterly
Mar 2025
-
$447.50M(-1.7%)
Dec 2024
$455.10M(+6.2%)
$455.10M(+81.0%)
Sep 2024
-
$251.40M(-1.9%)
Jun 2024
-
$256.20M(-50.0%)
Mar 2024
-
$511.90M(+19.5%)
Dec 2023
$428.40M(+63.0%)
$428.40M(+56.6%)
Sep 2023
-
$273.60M(-1.0%)
Jun 2023
-
$276.50M(+6.4%)
Mar 2023
-
$259.90M(-1.1%)
Dec 2022
$262.90M(-40.3%)
$262.90M(-1.1%)
Sep 2022
-
$265.80M(-1.0%)
Jun 2022
-
$268.60M(-44.1%)
Mar 2022
-
$480.20M(+9.0%)
Dec 2021
$440.40M(+6.8%)
$440.40M(+0.8%)
Sep 2021
-
$437.10M(+0.4%)
Jun 2021
-
$435.30M(+1.4%)
Mar 2021
-
$429.50M(+4.2%)
Dec 2020
$412.30M(-16.8%)
$412.30M(-18.8%)
Sep 2020
-
$508.00M(+0.8%)
Jun 2020
-
$503.80M(+0.8%)
Mar 2020
-
$499.70M(+0.8%)
Dec 2019
$495.50M(+27.5%)
$495.50M(+3.6%)
Sep 2019
-
$478.07M(+2.9%)
Jun 2019
-
$464.65M(+0.9%)
Mar 2019
-
$460.58M(+18.6%)
Dec 2018
$388.50M(+5.1%)
$388.50M(+1.3%)
Sep 2018
-
$383.65M(+1.3%)
Jun 2018
-
$378.88M(+1.2%)
Mar 2018
-
$374.21M(+1.2%)
Dec 2017
$369.62M(>+9900.0%)
$369.62M(+1.2%)
Sep 2017
-
$365.11M(+1.2%)
Jun 2017
-
$360.68M(>+9900.0%)
Mar 2017
-
$0.00(0.0%)
Dec 2016
$0.00(0.0%)
$0.00(0.0%)
Sep 2016
-
$0.00(0.0%)
Jun 2016
-
$0.00(0.0%)
Mar 2016
-
$0.00(0.0%)
Dec 2015
$0.00(0.0%)
$0.00(0.0%)
Sep 2015
-
$0.00(0.0%)
Jun 2015
-
$0.00(0.0%)
Mar 2015
-
$0.00(0.0%)
Dec 2014
$0.00(0.0%)
$0.00(0.0%)
Sep 2014
-
$0.00(0.0%)
Jun 2014
-
$0.00(0.0%)
Mar 2014
-
$0.00(0.0%)
Dec 2013
$0.00(0.0%)
$0.00(0.0%)
Sep 2013
-
$0.00(0.0%)
Jun 2013
-
$0.00(0.0%)
Mar 2013
-
$0.00(0.0%)
Dec 2012
$0.00(0.0%)
$0.00(0.0%)
Sep 2012
-
$0.00(0.0%)
Jun 2012
-
$0.00(0.0%)
Mar 2012
-
$0.00(0.0%)
Dec 2011
$0.00(0.0%)
$0.00(0.0%)
Sep 2011
-
$0.00(0.0%)
Jun 2011
-
$0.00(0.0%)
Mar 2011
-
$0.00(0.0%)
Dec 2010
$0.00
$0.00(-100.0%)
DateAnnualQuarterly
Sep 2010
-
$8.53M(-10.6%)
Jun 2010
-
$9.54M(-9.4%)
Mar 2010
-
$10.53M(>+9900.0%)
Dec 2009
$0.00(-100.0%)
$0.00(-100.0%)
Sep 2009
-
$17.28M(-4.9%)
Jun 2009
-
$18.16M(-0.3%)
Mar 2009
-
$18.22M(+18.3%)
Dec 2008
$15.40M(+936.1%)
$15.40M(+5478.6%)
Sep 2008
-
$276.00K(-54.1%)
Jun 2008
-
$601.00K(-41.4%)
Mar 2008
-
$1.02M(-31.0%)
Dec 2007
$1.49M(-97.2%)
$1.49M(-97.0%)
Sep 2007
-
$50.13M(-2.1%)
Jun 2007
-
$51.20M(-2.3%)
Mar 2007
-
$52.40M(-2.3%)
Dec 2006
$53.64M(-9.7%)
$53.64M(-2.5%)
Sep 2006
-
$54.99M(-2.6%)
Jun 2006
-
$56.45M(-2.6%)
Mar 2006
-
$57.95M(-2.4%)
Dec 2005
$59.40M(-10.2%)
$59.40M(-2.6%)
Sep 2005
-
$60.99M(-2.6%)
Jun 2005
-
$62.63M(-2.8%)
Mar 2005
-
$64.41M(-2.6%)
Dec 2004
$66.13M(+81.5%)
$66.13M(-3.7%)
Sep 2004
-
$68.70M(+16.7%)
Jun 2004
-
$58.88M(+24.9%)
Mar 2004
-
$47.13M(+29.4%)
Dec 2003
$36.43M(+359.1%)
$36.43M(+61.7%)
Sep 2003
-
$22.53M(+0.3%)
Jun 2003
-
$22.47M(+170.6%)
Mar 2003
-
$8.30M(+4.6%)
Dec 2002
$7.93M(+39.5%)
$7.93M(+18.6%)
Sep 2002
-
$6.69M(+19.6%)
Jun 2002
-
$5.59M(+9.3%)
Mar 2002
-
$5.12M(-10.1%)
Dec 2001
$5.69M(+47.0%)
$5.69M(+52.2%)
Sep 2001
-
$3.74M(-10.3%)
Jun 2001
-
$4.16M(+18.2%)
Mar 2001
-
$3.52M(-8.9%)
Dec 2000
$3.87M(+24.8%)
$3.87M(+26.6%)
Sep 2000
-
$3.06M(+16.1%)
Jun 2000
-
$2.63M(-8.4%)
Mar 2000
-
$2.87M(-7.3%)
Dec 1999
$3.10M(+3.3%)
$3.10M(0.0%)
Sep 1999
-
$3.10M(+34.8%)
Jun 1999
-
$2.30M(-36.1%)
Mar 1999
-
$3.60M(+20.0%)
Dec 1998
$3.00M(+87.5%)
$3.00M(>+9900.0%)
Sep 1998
-
$0.00(0.0%)
Jun 1998
-
$0.00(0.0%)
Mar 1998
-
$0.00(-100.0%)
Dec 1997
$1.60M(0.0%)
$1.60M(>+9900.0%)
Sep 1997
-
$0.00(0.0%)
Jun 1997
-
$0.00(0.0%)
Mar 1997
-
$0.00(-100.0%)
Dec 1996
$1.60M
$1.60M(>+9900.0%)
Sep 1996
-
$0.00(0.0%)
Jun 1996
-
$0.00(-100.0%)
Mar 1996
-
$2.20M

FAQ

  • What is Neurocrine Biosciences annual total debt?
  • What is the all time high annual total debt for Neurocrine Biosciences?
  • What is Neurocrine Biosciences annual total debt year-on-year change?
  • What is Neurocrine Biosciences quarterly total debt?
  • What is the all time high quarterly total debt for Neurocrine Biosciences?
  • What is Neurocrine Biosciences quarterly total debt year-on-year change?

What is Neurocrine Biosciences annual total debt?

The current annual total debt of NBIX is $455.10M

What is the all time high annual total debt for Neurocrine Biosciences?

Neurocrine Biosciences all-time high annual total debt is $495.50M

What is Neurocrine Biosciences annual total debt year-on-year change?

Over the past year, NBIX annual total debt has changed by +$26.70M (+6.23%)

What is Neurocrine Biosciences quarterly total debt?

The current quarterly total debt of NBIX is $447.50M

What is the all time high quarterly total debt for Neurocrine Biosciences?

Neurocrine Biosciences all-time high quarterly total debt is $511.90M

What is Neurocrine Biosciences quarterly total debt year-on-year change?

Over the past year, NBIX quarterly total debt has changed by -$64.40M (-12.58%)
On this page